Repligen Corporation's Earnings Preview: Expensive With Mixed Growth Prospects

Repligen Corporation (NASDAQ: RGEN ) is a prominent bioprocessing technology company developing equipment for streamlining the production of biological drugs. RGEN concentrates on key areas, such as process intensification, purification and analytics, and fluid management, providing solutions to simplify and enhance the efficiency ofMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree ...